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amending for the seventh time Council DirectiveT61T6S|EEC on the approximation of
the laws of the Member states relating to cosmetic products
(Text with EEA relevance)
1. B,c,cxcnouxn
Transmission of the Proposal to the Council and the European
Parliament - COM(2000) l39 final - 200010077 (COD) -
in accordance with article 175(1) of the Treaty:
Opinion of the Economic and Social Committee:
Opinion of the European Parliament - first reading:
6 April2000
20 September 2000
3 April2001.
2. On.rncrlvn oFTHE CoumrssroN PRoPoSAL
The main objective of the initial proposal was to pettle definitively the question of animal
testing in the cosmetic sector. The current legislative provisions providing the prohibition on
the marketing of cosmetic products containing ingredients or combinations of ingredients
tested on animals after 30 June 2000 (30 June 2002 following the second postponement by
Commission Directive 2000l4llEc) shall be amended so as to make them WTO-compliant,
legally and practically enforceable, thereby offering a genuine benefit to animal welfare.
The main elements of the initial proposal were:
the introduction of a permanent and definitive prohibition on the performance of tests
on animals for finished cosmetic products;
a switch from a marketing ban to a testing ban WTO compliant for ingredients and
combinations of ingredients used in cosmetic products. The date of implementation
of this ban is foresien three years after the date of implementation of the proposed
Directive. However, it should be postponed for no more than two years if there has
been insuffrcient progress in developing satisfactory methods to replace animal
testing scientifi callY validated;
a commitment that EU will take the lead in the intemational acceptance of alternative
methods, in particular through the adoption of bilateral agreements and negotiations
at OECD level;
to allow the use of claims indicating that animal testing has not been performed.
I{owever, to ensure that such claims do not mislead the consumer, the Commission,
in consultation with the Member States, will publish guidelines in order to clariff
their use.
In its amended proposal, the Commission has incorporated many suggestions of the European
Parliament, which aim to improve health and consumer protection.
3. CounalssloN oprNIoN oN THE AMENDMENTS ADoPTED BY THE PARLIAMENT
3.1. Amendments accepted in part or principle by the Commission: I (l't part)r 2, 4,
5,7 (2"d part), g t; n, 14 (2"0 uttd 3'u parts), 15 (2nd part 
- 
with the exception of
the suggested consultation of the European Parliament), 16 to 19r 23 (2"d part),
26,30,32 and 49 (2"d part)
The Commission can accept in principle the first part of amendrirent 1 and amendment 2
which propose the inclusion of a reference to Directive 86l609lEEC relating to the protection
of animals used for experimental and other scientific purposes. However, the reference
suggested in amendment 2 would be more relevant in recital 2 (as suggested by amendment 1)
than recital 3 which relates to the testing ban for finished products. To this end, recital2
should be amended as follows:
<Directive 86/609/EEC on the approximation of laws, regulations and administrative
provisions of the Member States regarding the protection of animals used for experimental
and other scientific purposes aims to ensuri that the number of animals usedfor experimental
purposes is reduced to a minimum. In accordance with Directive 93/35/EEC amendingfor the
sixth time Directive 76/768/EEC, it is essential that the aim of abolishing animal experiments
be pursued and thqt the prohibition of such experiments becomes ffictive on the territory of
the Member States.>
The Commission can
rewordins:
accept in principle amendr,nents 4 and 5 subject to the following
<In order to facilitate the rapid development of non-animal alternative tests, in particular
those tests which ore commonly used by other sectors and specified as regulatory
requirements in the Community, more coordinated action is needed at the Community and
national levels, includingfunding of relevant scientific research.>
<<The Commission has earmarked 17.5 billion Euro for the new framework programme for
reseorch and innovation in Europe over the period 2003-2006. In this context, the policy of
reduction, refinement and replacement of animal tests will be continued.>
The commission can accept in principle the 2nd part of amendment 7, as all interested parties,
including the NGOs, are consulted in the drafting of the guidelines, subject to the following
rewording:
<ln developing such guidelines, the Commission will consult all interested parties, including
the relevant NGOs>.
Directive 76l768lEEC already requires the safety assessment of products based on their
intended and foreseeable use. However, the Commission can accept the principle of
amendment 9 aiming to specify the safety requirements for cosmetic products intended for
children, subject to the firllowing rewording:
<Special guidance should be provided by the SCCNFP concerning the safety of products
intended for children. >
The Commission can accept in principle amendment l0 and the third part of amendment 14,
dealing with substances which are carcinogenig mutagenic and toxic for the reproduction
under th. D*g"rous substances Directive. Under Directive 76l768lEEC, cosmetic products
are already required not to cause any harm to human health, the mandatory safety assessment
provided by Article 7a(1) including potential mutagenic, carcinogenic or reprotoxic effects'
Furthermore, this issue is already taken into account by the Commission on a horizontal basis
in the proposed White Paper on the new chemical policy which plans to tan the use of
substances classified in categories I or 2 as carcinogenic, mutagenic or toxic for reproduction
under Annex I of Directive 67l548lEEC, except by following a procedure of authorisation
providing that companies show their safe use for certain purposes. Therefore, there is no need
for a specific provision in DirectiveT6lT6S|EEC.
The Commission can accept in principle the suggestions of amendments 11, 32 and 30 aiming
at improving information provided to consumers regarding the minimum durability of
cosmetic products, subject to the following rewording:
In the recital: <In order to improve the information provided to consumers, cosmetic products
should bear more precise indications concerning the durability of their use.>
Article 6(lXc) should be amended as follorys:
<(c).the date of minimum durability.
The date of minimum durability of a cosmetic product shall be the date until which this
product, siored under appropriate conditions, continues to fulfil its initial function and, in
particular, remains in conformity with Article 2-
The date of minimum durability shall be indicated by the date itself followed by the symbol
" + ". The date shatl be clearly expressed and shall consist of either the month and year or the
day, month and year in that order.
If necessary, this information shall be supplemented by an indication of the conditions which
must be satisfied to guarantee the stated durability->
The Commission can accept in principle amendment 12, the second part of amendment 21
and amendment 49 which iequire the inforrnation on the presence in cosmetic products of
nagt*c" ittgr"ai"nts with well-recognised potential to cause contact allergy. This
information will allow consumers, sensitive to these substances, to avoid cosmetic products
unsuitable to them. The labelling of such ingredients through an amendment of the current
Article 6.1.g) would answer the concems. To this end, the following rewording is proposed:
In the recital: <Certain substances have been identified os an important cause of contact-
allerg,, reactions in fragrance-sensitive consumers. In order to ensure that these consumers
oru idrquotely infoimri, it it therefore necessary to amend the provisions of the Directive so
as to require-the mention of these substances in the list referred to Article 6(I)(g), regardless
of their-source or function. This information will improve the diagnosis of contact allergies in
this population and will enable sensitised consumers to avoid products they may not
tolerate>.
Article 6(1Xg) should be amended as follows:
,,(g) a list of ingredients in descending order of weight at the time they are added. That list
s{a1 be pieceiud by be the word iingredients". Where that is impossible for practical
reasons, an enclosed leaflet, label, tape or card must contain the ingredients to which the
consumer is referred either by abbreviating information or the symbol given in Annex VIII
which must appear on the packaging.
The following shall not, however, be regarded as ingredients:
impurities in the raw materials used,
subsidiary technical materials used in the preparation but not present in the final
product,
materials used in strictly necessary quantities as solvents or as carriers for perfume
and aromatic compositions.
Perfume snd aromqtic compositions and their raw materials shall be refened to by the word
"perfum" or "aromo". However, the presence of substqnces, the mention of which is
required under the column <other limitations and requirementsD of Annex III, Part l, shall be
indicated in the list, irrespective of their function in the product.
Ingredients in concentrations of less than I ok may be listed in any order after those in
concentrations of more than I o%.
Colouring agents may be listed in any order after the other ingredients, in accordance with
the colour index number or'denomination adopted in Annex IV.
For decorative cosmetic: products marketed in several colour shades, all colouring agents
used in the range may be listed, provided that the tqrms "may contain" or the symbol "+/-"
ore added.
An ingredient must be identified by the common n(tme referred to in Article 7(2) or, failing
that, by one of the names referred to in Article 5a(2), first indent.
In accordance with the procedure laid down in Article 10, the Commission may adapt the
criteriq and conditions under which a manufacturer may, for reasons of trode secrecy, apply
not to include one or more ingredients on the above-mentioned list provided by Commission
Directive 95/17/EC of l9 June 1995 laying down detailed rules for the application of Council
Directive 76/768/EEC a:s regards the non-inclusion of one or more ingredients on the list
used for the labelling of cosmetic products. >
The Commission would accept the principle of the listing of the recognised fragrance
allergens in the Annex ITI according to the modalities suggested in amendment49 (setting of
threshold levels suggested by the SCCNFP), in line ,"ittt ttt. proposeO amended
Article 6(lXg). Howevet, according to Article 8(2) of Directive 76l768lEEC, the proposed
adaptation of Annex III, part 1, has to be done via a Commission Directive adopted under the
comitology procedure. Therefore, such technical adaptation should be done after the final
adoption of the Directive amending Article 6(l)(g), which would give the legal basis for such
a technical adaptation.
The Commission can accept to consider the principle of an introduction of a derogation to the
full testing ban for saferty reasons proposed by the second part of amendment 15 (with the
exception of the suggested consultation of the European Parliament), to ensure the key
objectives of consumer protection and public health, taking irrto account of the expected
progress in developing satisfactory methods to replace animal testing. However, the system of
such derogation restricted to existing ingredients should be reviewed to be implemented in a
non-discriminatory manner.
The Commission can accept in principle amendment 16 regarding the definition of finished
products, subject to the following rewording: <A "finished cosmetic product" shall mean the
cosmetic product in its final composition, as placed on the market and made available to the
final consumer.))
The Commission can accept in principle the second part of amendment 14, amendments 17,
18 and 19, which require additional information to be included in the Annual Report made by
th. C"-*ission, taking into account that the work done at OECD level is already part of the
existing Annual Report. However, in order to ensure a substantive evaluation of the progress
made and the collection of appropriate data, it is proposed to present the report on a three-year
basis. Therefore, the following rewording of the provision dealing with the Report is
proposed:
<Every three years the Commission shall present a report to the European Parliament and the
Council. That report shall contain:
a) on occount of the progress in the,development, validation and legal acceptance of
alternative methods to thos'e involving experiments on animals. It shall contain
precise data on the number and type of experiments relating to cosmetic products
' carried out on animals. The Member States shall be obliged to collect that
information in addition to collecting statistics as laid down by Directive 86/609/EEC
on the protection of animals usedfor experimental and othef scientific purposes;
b) an account of the progress made by the Commission in its efforts to obtain
acceptance by the Organisation for Economic Cooperation and Development
(OECD) of alternative methods validated at Community level, and to obtain, within
the framework of bilateral agreements with third countries, recognition of the results
of tests carried out in the Community using alternative methods sb as not to obstruct
the export of cosmetic products for which such methods have been used;
c) an account of the progress made in international fora, in particular the lVorH Trade
Organisation, to enhance the protection of animal welfare;
d) an explanation of how the economic and competition needs, of small and medium
enterprises in particular, have been taken into account in the implementation of
Article 4a.>
The provisions of the Directive already require the safety assessrnent of cosmetic products
based on their intended and foreseeable use. However, to give particular attention to cosmetic
products for children and intimate hygiene products, the Commission can accept in principle
amendment 26 subject to the following rewording: <(d) assessment of the safety for human
hratth of the finished product. To that end, the manufacturer shall take into consideration the
general toxicological profile of the ingredient, its chemical structure and its level of exposure.
He shall, in particulir, take into consideration the specific exposure characteristics of the
areas on which the product will be apptied or of the population for which it is intended. In
particular, there shilt be a specific assessment for cosmetic products intended exclusively for
'Ltse 
on chilcJrenunder the age of three andfor cosmetic products intended exclusivelyfor use
in intirnate hygiene.>
3.2. Amendments not accepted by the Commission: I (2"d part), 3, 7 (1't part), 13
and 14 (1't pant), 15 (1't pad), 20 nnd 21,23 (1't part), 27 and 28, 36 and 37, 39,
43,47 and 49 (1" part)
The Commission cannot accept the second part of amendment 1 and amendment 36, which
request the Commission to present other proposals, being contrary to the right of initiative of
the Commission.
The Commission cannot accept amendment 3 and the first part of amendment l5 dealing with
the EU testing ban for ingredients. The Commission cannot accept the deletion of the
postponement which aims to ensure the key objectives of consumer protection and public
health, taking into account the expected progress in developing. satisfactory methods to
replace animal testing scientifically validated as offering an equivalent level of protection for
the consumer. The Commission has to ensure a high level of consumer protection and
therefore to keep the possibility to postpone in case of lack of validation of key alternative
methods for this sector.
The Commission cannot accept the first part of amendment 7 and amendment 47 dealing with
the use of claims relating to animal testing. These are contrary to the intention of the
Commission proposal to avoid the use of such claims that mislead consumers by giving them
the impression that none of the ingredients contained in the products have been tested on
animals whilst such tests have necessarily been performed on almost every ingredient at least
once by someone. The aim of the Commission is to avoid misleading claims and give
complete information to consumers. The details should be dealt with in the production of
guidelines where all interested parties will be involved.
The Commission cannot accept amendments 13, 21 and 28 aiming at publishing all data
concerning each cosmetic product in the Inventory. Such information is part of the product
information required for the effective in-marliet control system established by the
6tn amendment to ensure free movement of goods while ensuring consumer safety. This is not
the purpose of the Inventory of cosmetic ingredients published by the Commission.
Furthermore, such a proposal would raise concerns in terms of industry property rights and
trade secrecy, and could lead to unfair competition, while not improving consunler
information.
The Commission cannot accept amendment 20 and the first part of amendment 23, which aim
to achieve a full ingredient listing, including for perfume composition. Such a full labelling of
all fragrance ingredients would neither be feasible or helpful to sensitised consumers or
dermatologists and would be disproportionate to the anticipated risks. Furthermore, these
amendments are in contradiction with amendment 12, the second part of amendment 23 and
amendment 49, aiming at introducing a labelling system for the fragrance ingredients with
well-recognised potential to cause contact allergy, that the Commission has accepted in
principle.
The Commission initial proposal provided a switch from the marketing ban to an EU testing
ban WTO-compliant, legally and practically enforceable, thereby offering a genuine benefit to
animal welfare. The Commission cannot accept amendment 37 and the first part of
amendment 14 reintroducing the marketing ban as and when alternatives are available, with a
def-tttte d"te after which no products can be marketed if tested on animals, whether or not
there are validated alternatives. It is not in conformity with WTo-rules and likely to be
challenged. As already r;tated in recital 5 of the initial proposal, the Commission will pursue
its effort to promote rapid international acceptance of altemative methods at OCDE level.
Having noticed the concerns of the public opinion, it will stimulate discussions on trade and
animal welfare in a multilateral forum. A unilateral Community ban on marketing rvould be
contrary to the policy of a multilateral approach to animal welfare trade issues' The
Community has taken a position that discussions on trade and animal welfare (and other
PPMs issues) should be done in a multilateral forum. A unilateral action by the Community
such as the proposed marketing ban would undermine this multilateral approach. The
Commission underlines its commitment to the use of international standards as a basis for
measures which have a trade impact. The Community would be in contradiction with its
intemational commitments to accept the results of tests carried out on animals in third
countries because of the mutual acceptance of data agreement. Furthermore, considering the
development of alternatives, the time scale suggested for its implementation is not realistic. It
shouliltake into account the development and international acceptance of alternative methods
to ensure that consumer safety would not be endangered. Only a co-ordinated approach at
international level would improve animal welfare, and on a wider scale'
The Commission cannot accept amendment 27, suggesting additional data on animal tests
performed to be included in the product information required for each cosmetic product put
-on 
the market. This additional requirement obliging the manufacturer to check if any of the
ingredients used have been once tested on animals somewhere in the world is impossible to
fulfil, and could raise concerns under the TBT agreement (Article 5'2.3).
The Commission cannot accept the additional requirement of a compulsory labelling "tested
on animals" required by amendments 37 and 39. Such amendment is not proportionate and
may raise concerns, among others under the TBT agreement, as most imported products
woqld bear this mention.
The Commission cannot accept amendment 43 aiming to avoid use of fragrances in some
categories except when they fulfil specific purposes. The suggested ban would be contrary to
the principles of necessity and proportionality. The Commission has already accepted to
reinforce iafety requirements for some categories of products such as products for children
and intimate hygiene products, as suggested by amendment26.
3.3. Amended proposal
Having regard to Article 250, paragraph2, of the EC Treaty, the Commission amends its
proposal as indicated above.
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